首页 > 最新文献

Saudi Journal of Gastroenterology最新文献

英文 中文
Artificial intelligence in endoscopy: Overview, applications, and future directions. 人工智能在内窥镜检查中的应用综述及未来发展方向。
IF 1.9 4区 医学 Q3 GASTROENTEROLOGY & HEPATOLOGY Pub Date : 2023-09-01 Epub Date: 2023-09-06 DOI: 10.4103/sjg.sjg_286_23
Arif A Arif, Shirley X Jiang, Michael F Byrne

Since the emergence of artificial intelligence (AI) in medicine, endoscopy applications in gastroenterology have been at the forefront of innovations. The ever-increasing number of studies necessitates the need to organize and classify applications in a useful way. Separating AI capabilities by computer aided detection (CADe), diagnosis (CADx), and quality assessment (CADq) allows for a systematic evaluation of each application. CADe studies have shown promise in accurate detection of esophageal, gastric and colonic neoplasia as well as identifying sources of bleeding and Crohn's disease in the small bowel. While more advanced CADx applications employ optical biopsies to give further information to characterize neoplasia and grade inflammatory disease, diverse CADq applications ensure quality and increase the efficiency of procedures. Future applications show promise in advanced therapeutic modalities and integrated systems that provide multimodal capabilities. AI is set to revolutionize clinical decision making and performance of endoscopy.

自人工智能(AI)在医学领域出现以来,内窥镜在胃肠病学中的应用一直处于创新的前沿。越来越多的研究需要以有用的方式对应用程序进行组织和分类。通过计算机辅助检测(CADe)、诊断(CADx)和质量评估(CADq)分离人工智能功能,可以对每个应用程序进行系统评估。CADe研究已经显示出在准确检测食管、胃和结肠肿瘤,以及识别小肠出血和克罗恩病来源方面的前景。虽然更先进的CADx应用采用光学活检来提供进一步的信息来表征肿瘤和炎症性疾病的等级,但多样化的CADq应用确保了质量并提高了程序的效率。未来的应用有望在先进的治疗方式和提供多模式能力的综合系统。人工智能将彻底改变临床决策和内窥镜检查的表现。
{"title":"Artificial intelligence in endoscopy: Overview, applications, and future directions.","authors":"Arif A Arif, Shirley X Jiang, Michael F Byrne","doi":"10.4103/sjg.sjg_286_23","DOIUrl":"10.4103/sjg.sjg_286_23","url":null,"abstract":"<p><p>Since the emergence of artificial intelligence (AI) in medicine, endoscopy applications in gastroenterology have been at the forefront of innovations. The ever-increasing number of studies necessitates the need to organize and classify applications in a useful way. Separating AI capabilities by computer aided detection (CADe), diagnosis (CADx), and quality assessment (CADq) allows for a systematic evaluation of each application. CADe studies have shown promise in accurate detection of esophageal, gastric and colonic neoplasia as well as identifying sources of bleeding and Crohn's disease in the small bowel. While more advanced CADx applications employ optical biopsies to give further information to characterize neoplasia and grade inflammatory disease, diverse CADq applications ensure quality and increase the efficiency of procedures. Future applications show promise in advanced therapeutic modalities and integrated systems that provide multimodal capabilities. AI is set to revolutionize clinical decision making and performance of endoscopy.</p>","PeriodicalId":48881,"journal":{"name":"Saudi Journal of Gastroenterology","volume":"29 5","pages":"269-277"},"PeriodicalIF":1.9,"publicationDate":"2023-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10644999/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"134650199","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The when, why and whom to biopsy of type 1 diabetes mellitus children with positive anti-tissue transglutaminase serology. 抗组织转谷氨酰胺酶血清学阳性的1型糖尿病儿童何时、为什么以及由谁进行活检。
IF 2.7 4区 医学 Q3 GASTROENTEROLOGY & HEPATOLOGY Pub Date : 2023-09-01 Epub Date: 2023-08-09 DOI: 10.4103/sjg.sjg_253_23
Stefano Guandalini
{"title":"The when, why and whom to biopsy of type 1 diabetes mellitus children with positive anti-tissue transglutaminase serology.","authors":"Stefano Guandalini","doi":"10.4103/sjg.sjg_253_23","DOIUrl":"10.4103/sjg.sjg_253_23","url":null,"abstract":"","PeriodicalId":48881,"journal":{"name":"Saudi Journal of Gastroenterology","volume":" ","pages":"257-258"},"PeriodicalIF":2.7,"publicationDate":"2023-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10645000/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10029537","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
IBD-Disk as a tool estimating the prevalence of inflammatory bowel disease-related disability and associated influencing factors in Saudi Arabia: A cross-sectional study. IBD椎间盘作为评估沙特阿拉伯炎症性肠病相关残疾患病率及相关影响因素的工具:一项横断面研究。
IF 2.7 4区 医学 Q3 GASTROENTEROLOGY & HEPATOLOGY Pub Date : 2023-09-01 Epub Date: 2023-06-08 DOI: 10.4103/sjg.sjg_3_23
Yaser Meeralam, Adnan B Al-Zanbagi, Mona Al Saedi, Walaa Alharthi, Hanadi A Sabbahi, Talal Alhejaili, Mohammed K Shariff

Background: Inflammatory bowel disease (IBD) disk is an easy tool to use in clinical practice to measure IBD-related disability, with a score >40 correlating with high daily-life burden. Its use has been limited mainly to the western world. We aimed to estimate the prevalence of IBD-related disability and evaluate the associated risk factors in Saudi Arabia.

Methods: In this cross sectional study conducted at a tertiary referral center for IBD, the English IBD disk was translated into Arabic, and patients with IBD were approached to complete it. Total IBD disk score (0 = no disability; 100 = severe disability) was documented and a score of >40 was set as a threshold to estimate the prevalence of disability.

Results: Eighty patients with a mean age of 32.5 ± 11.9 years and disease duration of 6 years, including 57% females, were analyzed. The mean IBD-disk total score was 20.70 ± 18.69. The mean subscores for each function within the disk ranged from 0.38 ± 1.69 for sexual functions to 3.61 ± 3.29 for energy. The overall prevalence of IBD-related disability was 19% (15/80 scoring >40) and was much higher in active disease, in males and in IBD of long duration (39%, 24%, and 26%, respectively). A clinically active disease, high CRP, and high calprotectin were strongly associated with higher disk scores.

Conclusion: Although the overall mean IBD disk score was low, nearly 19% of our population had high scores signifying a high prevalence of disability. As demonstrated by other studies, active disease and high biomarkers were significantly associated with higher IBD-disk scores.

背景:炎症性肠病(IBD)椎间盘是一种在临床实践中用于测量IBD相关残疾的简单工具,评分>40与高日常生活负担相关。它的使用主要局限于西方世界。我们旨在估计沙特阿拉伯IBD相关残疾的患病率并评估相关的风险因素。方法:在这项在IBD三级转诊中心进行的横断面研究中,将英文IBD盘翻译成阿拉伯语,并联系IBD患者完成它。IBD椎间盘总评分(0=无残疾;100=严重残疾)被记录在案,评分>40被设定为评估残疾患病率的阈值。结果:分析了80例患者,平均年龄32.5±11.9岁,病程6年,其中57%为女性。IBD椎间盘平均总分为20.70±18.69。椎间盘内每个功能的平均分量表范围从性功能的0.38±1.69到能量的3.61±3.29。IBD相关残疾的总体患病率为19%(15/80评分>40),活动性疾病、男性和长期IBD的患病率高得多(分别为39%、24%和26%)。临床活动性疾病、高CRP和高钙卫蛋白与较高的椎间盘评分密切相关。结论:尽管IBD椎间盘的总体平均得分较低,但近19%的人群得分较高,这意味着残疾的患病率较高。正如其他研究所表明的,活动性疾病和高生物标志物与较高的IBD椎间盘评分显著相关。
{"title":"IBD-Disk as a tool estimating the prevalence of inflammatory bowel disease-related disability and associated influencing factors in Saudi Arabia: A cross-sectional study.","authors":"Yaser Meeralam, Adnan B Al-Zanbagi, Mona Al Saedi, Walaa Alharthi, Hanadi A Sabbahi, Talal Alhejaili, Mohammed K Shariff","doi":"10.4103/sjg.sjg_3_23","DOIUrl":"10.4103/sjg.sjg_3_23","url":null,"abstract":"<p><strong>Background: </strong>Inflammatory bowel disease (IBD) disk is an easy tool to use in clinical practice to measure IBD-related disability, with a score >40 correlating with high daily-life burden. Its use has been limited mainly to the western world. We aimed to estimate the prevalence of IBD-related disability and evaluate the associated risk factors in Saudi Arabia.</p><p><strong>Methods: </strong>In this cross sectional study conducted at a tertiary referral center for IBD, the English IBD disk was translated into Arabic, and patients with IBD were approached to complete it. Total IBD disk score (0 = no disability; 100 = severe disability) was documented and a score of >40 was set as a threshold to estimate the prevalence of disability.</p><p><strong>Results: </strong>Eighty patients with a mean age of 32.5 ± 11.9 years and disease duration of 6 years, including 57% females, were analyzed. The mean IBD-disk total score was 20.70 ± 18.69. The mean subscores for each function within the disk ranged from 0.38 ± 1.69 for sexual functions to 3.61 ± 3.29 for energy. The overall prevalence of IBD-related disability was 19% (15/80 scoring >40) and was much higher in active disease, in males and in IBD of long duration (39%, 24%, and 26%, respectively). A clinically active disease, high CRP, and high calprotectin were strongly associated with higher disk scores.</p><p><strong>Conclusion: </strong>Although the overall mean IBD disk score was low, nearly 19% of our population had high scores signifying a high prevalence of disability. As demonstrated by other studies, active disease and high biomarkers were significantly associated with higher IBD-disk scores.</p>","PeriodicalId":48881,"journal":{"name":"Saudi Journal of Gastroenterology","volume":"29 5","pages":"309-315"},"PeriodicalIF":2.7,"publicationDate":"2023-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10644998/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"41136456","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Frequency and predictive factors for spontaneous normalization of anti-tissue transglutaminase-IgA serology among Saudi children with type 1 diabetes mellitus: A cohort study. 沙特1型糖尿病儿童抗组织转谷氨酰胺酶IgA血清学自发正常化的频率和预测因素:一项队列研究。
IF 2.7 4区 医学 Q3 GASTROENTEROLOGY & HEPATOLOGY Pub Date : 2023-09-01 DOI: 10.4103/sjg.sjg_25_23
Ahmed Al Sarkhy, Ali Al Hassan, Heba Assiri, Hayfa Alabdulkarim, Noor AlAnazi, Nawaf Alshammari, Najla AlOtaibi, Mona Al Asmi, Asaad Assiri, Reem Al-Khalifah, Shaik Shaffi Ahamed, Mohammad El Mouzan

Background: Celiac serology can be transiently elevated in patients with type 1 diabetes mellitus (T1DM) and normalized despite gluten consumption. This study aimed to identify the frequency and predictive factors of spontaneous normalization of anti-tissue transglutaminase (anti-TTG-IgA) antibodies in these patients.

Methods: The charts of all patients (≤18 years) with T1DM were retrospectively reviewed from 2012 to 2021 at a tertiary care center in Riyadh, Saudi Arabia. The following data were collected: clinical characteristics of the participants, anti-TTG-IgA-immunoglobulin (Ig) A antibody, and histological findings. The outcome of positive anti-TTG-IgA-IgA in patients with T1DM and the predictive factors for spontaneous normalization were investigated.

Results: Of the 1,006 patients with T1DM, 138 (13.7%) had elevated anti-TTG-IgA antibodies, celiac disease was diagnosed in 58/138 (42%) patients, spontaneous normalization of anti-TTG-IgA was observed in 65 (47.1%) patients, and fluctuating anti-TTG-IgA antibodies were seen in 15 (10.9%) patients. The patients with anti-TTG-IgA levels at 3-10 times the upper normal limits (UNL), and those with levels ≥10 times UNL were less likely to have spontaneous normalization of anti-TTG-IgA compared to patients with levels at 1-3 times UNL (hazard ratio [HR] = 0.28, 95% confidence interval [Cl] = 0.13-0.61, P = 0.001, and HR = 0.03, 95% Cl = 0.00-0.19, P < 0.001, respectively).

Conclusion: Asymptomatic patients with T1DM with mild elevation of anti-TTG-IgA need not be rushed for invasive endoscopy or exposed to an un-needed gluten-free diet but should rather have a regular follow-up of their celiac serology.

背景:1型糖尿病(T1DM)患者的腹腔血清学可暂时升高,尽管食用了麸质,但仍能正常化。本研究旨在确定这些患者中抗组织转谷氨酰胺酶(抗TTG-IgA)抗体自发正常化的频率和预测因素。方法:回顾性回顾2012年至2021年在沙特阿拉伯利雅得一家三级护理中心接受治疗的所有T1DM患者(≤18岁)的病历。收集了以下数据:参与者的临床特征、抗TTG IgA免疫球蛋白(Ig)A抗体和组织学发现。研究了T1DM患者抗TTG IgA IgA阳性的结果以及自发正常化的预测因素。结果:在1006例T1DM患者中,138例(13.7%)抗TTG IgA抗体升高,58/138例(42%)患者诊断为乳糜泻,65例(47.1%)患者观察到抗TTG IgG抗体自发正常化,15例(10.9%)患者抗TTG抗体波动。与水平为正常上限(UNL)1-3倍的患者相比,抗TTG IgA水平为正常下限3-10倍的患者和水平≥正常上限10倍的患者抗TTG IgG自发正常化的可能性较小(风险比[HR]=0.28,95%置信区间[Cl]=0.13-0.61,P=0.001,HR=0.03,95%CI=0.00-0.19,P<0.001)。结论:抗TTG IgA轻度升高的无症状T1DM患者不需要立即进行侵入性内窥镜检查或接触不需要的无麸质饮食,而是应该定期随访其腹腔血清学。
{"title":"Frequency and predictive factors for spontaneous normalization of anti-tissue transglutaminase-IgA serology among Saudi children with type 1 diabetes mellitus: A cohort study.","authors":"Ahmed Al Sarkhy, Ali Al Hassan, Heba Assiri, Hayfa Alabdulkarim, Noor AlAnazi, Nawaf Alshammari, Najla AlOtaibi, Mona Al Asmi, Asaad Assiri, Reem Al-Khalifah, Shaik Shaffi Ahamed, Mohammad El Mouzan","doi":"10.4103/sjg.sjg_25_23","DOIUrl":"10.4103/sjg.sjg_25_23","url":null,"abstract":"<p><strong>Background: </strong>Celiac serology can be transiently elevated in patients with type 1 diabetes mellitus (T1DM) and normalized despite gluten consumption. This study aimed to identify the frequency and predictive factors of spontaneous normalization of anti-tissue transglutaminase (anti-TTG-IgA) antibodies in these patients.</p><p><strong>Methods: </strong>The charts of all patients (≤18 years) with T1DM were retrospectively reviewed from 2012 to 2021 at a tertiary care center in Riyadh, Saudi Arabia. The following data were collected: clinical characteristics of the participants, anti-TTG-IgA-immunoglobulin (Ig) A antibody, and histological findings. The outcome of positive anti-TTG-IgA-IgA in patients with T1DM and the predictive factors for spontaneous normalization were investigated.</p><p><strong>Results: </strong>Of the 1,006 patients with T1DM, 138 (13.7%) had elevated anti-TTG-IgA antibodies, celiac disease was diagnosed in 58/138 (42%) patients, spontaneous normalization of anti-TTG-IgA was observed in 65 (47.1%) patients, and fluctuating anti-TTG-IgA antibodies were seen in 15 (10.9%) patients. The patients with anti-TTG-IgA levels at 3-10 times the upper normal limits (UNL), and those with levels ≥10 times UNL were less likely to have spontaneous normalization of anti-TTG-IgA compared to patients with levels at 1-3 times UNL (hazard ratio [HR] = 0.28, 95% confidence interval [Cl] = 0.13-0.61, P = 0.001, and HR = 0.03, 95% Cl = 0.00-0.19, P < 0.001, respectively).</p><p><strong>Conclusion: </strong>Asymptomatic patients with T1DM with mild elevation of anti-TTG-IgA need not be rushed for invasive endoscopy or exposed to an un-needed gluten-free diet but should rather have a regular follow-up of their celiac serology.</p>","PeriodicalId":48881,"journal":{"name":"Saudi Journal of Gastroenterology","volume":" ","pages":"278-285"},"PeriodicalIF":2.7,"publicationDate":"2023-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10645001/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9577950","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Oncological outcomes of elective versus emergency surgery for colon cancer: A tertiary academic center experience. 癌症择期手术与急诊手术的肿瘤结果:三级学术中心经验。
IF 2.7 4区 医学 Q3 GASTROENTEROLOGY & HEPATOLOGY Pub Date : 2023-09-01 DOI: 10.4103/sjg.sjg_31_23
Thamer A Bin Traiki, Sulaiman A AlShammari, Razan N AlRabah, Amirah M AlZahrani, Saud T Alshenaifi, Noura S Alhassan, Maha-Hamadien Abdulla, Ahmad M Zubaidi, Omar A Al-Obeed, Khayal A Alkhayal

Background: In this study, we aimed to identify the oncological outcomes in colon cancer patients who underwent elective versus emergency curative resection.

Methods: All patients who underwent curative resection for colon cancer between July 2015 and December 2019 were retrospectively reviewed and analyzed. Patients were divided into two groups based on the presentation into elective and emergency groups.

Results: A total of 215 patients with colon cancer were admitted and underwent curative surgical resection. Of those, 145 patients (67.4%) were elective cases, and 70 (32.5%) were emergency cases. Family history of malignancy was positive in 44 patients (20.5%) and significantly more common in the emergency group (P = 0.016). The emergency group had higher T and TNM stages (P = 0.001). The 3-year survival rate was 60.9% and significantly less in the emergency group (P = 0.026). The mean duration from surgery to recurrence, 3-year disease-free survival, and overall survival were 1.19, 2.81, and 3.11, respectively.

Conclusion: Elective group was associated with better 3-year survival, longer overall, and 3-year disease-free survival compared to the emergency group. The disease recurrence rate was comparable in both groups, mainly in the first two years after curative resection.

背景:在这项研究中,我们旨在确定癌症患者接受选择性和紧急治疗性切除的肿瘤结果。方法:回顾性分析2015年7月至2019年12月期间所有接受癌症根治性切除术的患者。根据表现将患者分为两组,分别为选择性组和急诊组。结果:共有215例癌症患者入院接受治疗性手术切除。其中145例(67.4%)为择期病例,70例(32.5%)为急诊病例。44名患者(20.5%)有恶性肿瘤家族史,急诊组更常见(P=0.016)。急诊组有较高的T和TNM分期(P=0.001)。3年生存率为60.9%,急诊组明显更低(P=0.026)。从手术到复发的平均持续时间、3年无病生存率和总生存率分别为1.19、2.81、,和3.11。结论:与急诊组相比,选择性组的3年生存率更好,总体生存期更长,3年无病生存期更长。两组的疾病复发率相当,主要发生在根治性切除后的前两年。
{"title":"Oncological outcomes of elective versus emergency surgery for colon cancer: A tertiary academic center experience.","authors":"Thamer A Bin Traiki, Sulaiman A AlShammari, Razan N AlRabah, Amirah M AlZahrani, Saud T Alshenaifi, Noura S Alhassan, Maha-Hamadien Abdulla, Ahmad M Zubaidi, Omar A Al-Obeed, Khayal A Alkhayal","doi":"10.4103/sjg.sjg_31_23","DOIUrl":"10.4103/sjg.sjg_31_23","url":null,"abstract":"<p><strong>Background: </strong>In this study, we aimed to identify the oncological outcomes in colon cancer patients who underwent elective versus emergency curative resection.</p><p><strong>Methods: </strong>All patients who underwent curative resection for colon cancer between July 2015 and December 2019 were retrospectively reviewed and analyzed. Patients were divided into two groups based on the presentation into elective and emergency groups.</p><p><strong>Results: </strong>A total of 215 patients with colon cancer were admitted and underwent curative surgical resection. Of those, 145 patients (67.4%) were elective cases, and 70 (32.5%) were emergency cases. Family history of malignancy was positive in 44 patients (20.5%) and significantly more common in the emergency group (P = 0.016). The emergency group had higher T and TNM stages (P = 0.001). The 3-year survival rate was 60.9% and significantly less in the emergency group (P = 0.026). The mean duration from surgery to recurrence, 3-year disease-free survival, and overall survival were 1.19, 2.81, and 3.11, respectively.</p><p><strong>Conclusion: </strong>Elective group was associated with better 3-year survival, longer overall, and 3-year disease-free survival compared to the emergency group. The disease recurrence rate was comparable in both groups, mainly in the first two years after curative resection.</p>","PeriodicalId":48881,"journal":{"name":"Saudi Journal of Gastroenterology","volume":" ","pages":"316-322"},"PeriodicalIF":2.7,"publicationDate":"2023-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10644994/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9227799","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Efficacy of early biologic therapy versus late/conventional therapy in children and adolescents with Crohn's disease: A systematic review and meta-analysis. 儿童和青少年克罗恩病早期生物治疗与晚期/常规治疗的疗效:一项系统综述和荟萃分析。
IF 2.7 4区 医学 Q3 GASTROENTEROLOGY & HEPATOLOGY Pub Date : 2023-09-01 Epub Date: 2023-09-15 DOI: 10.4103/sjg.sjg_190_23
Lei Zhang, Zhixiao Jin, Jia Hao

Background: The objective of this study was to estimate the effectiveness of early biologics compared to conventional treatment in the management of Crohn's disease among pediatric and adolescent patients.

Methods: A comprehensive literature search was conducted in four electronic databases to identify relevant studies published from inception to 2023. The inclusion criteria comprised randomized controlled trials (RCTs) and cohort studies that reported on the efficacy and clinical outcomes of early biologic therapy compared to late/conventional therapy in children with Crohn's disease. The quality of the studies was assessed using the Cochrane Risk of Bias tool and the Newcastle Ottawa scale.

Results: A total of 13 studies (2 RCTs and 11 cohort studies), involving 861 patients, were included in the meta-analysis. The results demonstrated that early biologic therapy was associated with a significantly higher rate of clinical remission (risk ratio [RR] 1.30, 95% confidence interval [CI] 1.10-1.54), lower relapse rates (RR 0.33, 95% CI 0.21-0.53), and improved mucosal healing (RR 1.47, 95% CI 1.10-1.97) compared to late/conventional therapy. However, it should be noted that there was evidence of publication bias among studies reporting clinical remission.

Conclusion: In conclusion, early biologic therapy is significantly more effective in achieving clinical remission (within two years of diagnosis), promoting mucosal healing, and reducing relapse rates in pediatric and adolescent patients with Crohn's disease, compared to late/conventional therapy. These findings emphasize the importance of initiating biological therapy early in the treatment of Crohn's disease in this patient population.

背景:本研究的目的是评估早期生物制剂与传统治疗相比在儿童和青少年患者中治疗克罗恩病的有效性。方法:在四个电子数据库中进行全面的文献检索,以确定从开始到2023年发表的相关研究。纳入标准包括随机对照试验(RCT)和队列研究,这些研究报告了克罗恩病儿童早期生物治疗与晚期/常规治疗的疗效和临床结果。使用Cochrane偏倚风险工具和Newcastle Ottawa量表评估研究质量。结果:共有13项研究(2项随机对照试验和11项队列研究)纳入荟萃分析,涉及861名患者。结果表明,与晚期/常规治疗相比,早期生物治疗具有显著更高的临床缓解率(风险比[RR]1.30,95%置信区间[CI]1.10-1.54)、更低的复发率(RR 0.33,95%CI 0.21-0.53)和改善粘膜愈合(RR 1.47,95%CI 1.10-1.97)。然而,应该注意的是,有证据表明,在报告临床缓解的研究中存在发表偏倚。结论:总之,与晚期/常规治疗相比,早期生物治疗在实现儿童和青少年克罗恩病患者的临床缓解(诊断后两年内)、促进粘膜愈合和降低复发率方面明显更有效。这些发现强调了在该患者群体中尽早开始生物治疗克罗恩病的重要性。
{"title":"Efficacy of early biologic therapy versus late/conventional therapy in children and adolescents with Crohn's disease: A systematic review and meta-analysis.","authors":"Lei Zhang, Zhixiao Jin, Jia Hao","doi":"10.4103/sjg.sjg_190_23","DOIUrl":"10.4103/sjg.sjg_190_23","url":null,"abstract":"<p><strong>Background: </strong>The objective of this study was to estimate the effectiveness of early biologics compared to conventional treatment in the management of Crohn's disease among pediatric and adolescent patients.</p><p><strong>Methods: </strong>A comprehensive literature search was conducted in four electronic databases to identify relevant studies published from inception to 2023. The inclusion criteria comprised randomized controlled trials (RCTs) and cohort studies that reported on the efficacy and clinical outcomes of early biologic therapy compared to late/conventional therapy in children with Crohn's disease. The quality of the studies was assessed using the Cochrane Risk of Bias tool and the Newcastle Ottawa scale.</p><p><strong>Results: </strong>A total of 13 studies (2 RCTs and 11 cohort studies), involving 861 patients, were included in the meta-analysis. The results demonstrated that early biologic therapy was associated with a significantly higher rate of clinical remission (risk ratio [RR] 1.30, 95% confidence interval [CI] 1.10-1.54), lower relapse rates (RR 0.33, 95% CI 0.21-0.53), and improved mucosal healing (RR 1.47, 95% CI 1.10-1.97) compared to late/conventional therapy. However, it should be noted that there was evidence of publication bias among studies reporting clinical remission.</p><p><strong>Conclusion: </strong>In conclusion, early biologic therapy is significantly more effective in achieving clinical remission (within two years of diagnosis), promoting mucosal healing, and reducing relapse rates in pediatric and adolescent patients with Crohn's disease, compared to late/conventional therapy. These findings emphasize the importance of initiating biological therapy early in the treatment of Crohn's disease in this patient population.</p>","PeriodicalId":48881,"journal":{"name":"Saudi Journal of Gastroenterology","volume":"29 5","pages":"259-268"},"PeriodicalIF":2.7,"publicationDate":"2023-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10644997/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"41155233","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Predictors of biliary atresia outcome: Saudi National Study (2000 - 2018). 胆道闭锁结局的预测因素:沙特国家研究(2000 - 2018)。
IF 2.7 4区 医学 Q3 GASTROENTEROLOGY & HEPATOLOGY Pub Date : 2023-09-01 Epub Date: 2023-03-20 DOI: 10.4103/sjg.sjg_512_22
Mohammed Abanemai, Mohammed AlEdreesi, Ahmed Al Sarkhy, Omar I Saadah, Homoud Alhebbi, Razan Bader, Maher Alhatlani, Hana Halabi, Ahmed Aladsani, Sami Wali, Talal Alguofi, Fahad Alsayed, Amira NasserAllah, Ahmed Almehmadi, Afnan Qurban, Muhammed Salman Bashir, Aisha Alamri, Abdulrahman Al-Hussaini

Background: Outcomes in biliary atresia (BA) have been well-documented in large national cohorts from Europe, North America, and East Asia. Understanding the challenges that preclude success of the Kasai portoenterostomy (KPE) is the key to improve the overall outcomes of BA and implementing intervention strategies. Here, we analyzed the data from the Saudi national BA study (204 BA cases diagnosed between 2000 and 2018) to identify the prognostic factors of BA outcomes.

Methods: One hundred and forty-three cases underwent KPE. Several prognostic factors (center case load, congenital anomalies, serum gamma-glutamyl transferase, use of steroids, ascending cholangitis post-operatively, and degree of portal fibrosis at time of KPE) were investigated and correlated with the primary outcomes of interest: 1) success of KPE (clearance of jaundice and total serum bilirubin <20 mmol/l after KPE), 2) survival with native liver (SNL), and 3) overall survival.

Results: Use of steroids after KPE was associated with clearance of jaundice, 68% vs. 36.8% in the BA cases that did not receive steroids (P = 0.013; odds ratio 2.5) and a significantly better SNL rate at 2 - and 10-year of 62.22% and 57.77% vs. 39.47% and 31.57%, respectively (P = 0.01). A better 10-year SNL was observed in centers with caseload <1/year (group 1) as compared to centers that performed ≥1/year (group 2) [45.34% vs. 26.66%, respectively; P = 0.047]. On comparison of the 2 groups, cases in group 1 had KPE at significantly earlier age (median 59.5 vs. 75 days, P = 0.006) and received steroids after KPE more frequently than group 2 (69% vs. 31%, P < 0.001). None of the remaining prognostic variables were identified as being significantly related to BA outcome.

Conclusion: Steroids use post-KPE predicted clearance of jaundice and better short- and long-term SNL. There is a need to establish a national BA registry in Saudi Arabia aiming to standardize the pre- and post-operative clinical practices and facilitate clinical and basic research to evaluate factors that influence BA outcome.

背景:在欧洲、北美和东亚的大型国家队列中,胆道闭锁(BA)的结局已经得到了充分的记录。了解阻碍Kasai门肠造口术(KPE)成功的挑战是改善BA整体结果和实施干预策略的关键。在这里,我们分析了沙特国家BA研究的数据(2000年至2018年间诊断的204例BA病例),以确定BA结果的预后因素。方法:143例患者行KPE。研究了几个预后因素(中心病例负荷、先天性异常、血清γ -谷氨酰转移酶、使用类固醇、术后升性胆管炎和KPE时的门脉纤维化程度)并与主要结果相关:1)KPE成功(黄疸清除率和血清总胆红素)结果:KPE后使用类固醇与黄疸清除率相关,68% vs.未接受类固醇的BA病例为36.8% (P = 0.013;优势比2.5),2年和10年SNL率分别为62.22%和57.77%,比39.47%和31.57% (P = 0.01)。结论:kpe后使用类固醇可预测黄疸清除率和较好的短期和长期SNL。有必要在沙特阿拉伯建立一个全国性的BA登记处,旨在规范术前和术后临床实践,促进临床和基础研究,以评估影响BA结果的因素。
{"title":"Predictors of biliary atresia outcome: Saudi National Study (2000 - 2018).","authors":"Mohammed Abanemai, Mohammed AlEdreesi, Ahmed Al Sarkhy, Omar I Saadah, Homoud Alhebbi, Razan Bader, Maher Alhatlani, Hana Halabi, Ahmed Aladsani, Sami Wali, Talal Alguofi, Fahad Alsayed, Amira NasserAllah, Ahmed Almehmadi, Afnan Qurban, Muhammed Salman Bashir, Aisha Alamri, Abdulrahman Al-Hussaini","doi":"10.4103/sjg.sjg_512_22","DOIUrl":"https://doi.org/10.4103/sjg.sjg_512_22","url":null,"abstract":"<p><strong>Background: </strong>Outcomes in biliary atresia (BA) have been well-documented in large national cohorts from Europe, North America, and East Asia. Understanding the challenges that preclude success of the Kasai portoenterostomy (KPE) is the key to improve the overall outcomes of BA and implementing intervention strategies. Here, we analyzed the data from the Saudi national BA study (204 BA cases diagnosed between 2000 and 2018) to identify the prognostic factors of BA outcomes.</p><p><strong>Methods: </strong>One hundred and forty-three cases underwent KPE. Several prognostic factors (center case load, congenital anomalies, serum gamma-glutamyl transferase, use of steroids, ascending cholangitis post-operatively, and degree of portal fibrosis at time of KPE) were investigated and correlated with the primary outcomes of interest: 1) success of KPE (clearance of jaundice and total serum bilirubin <20 mmol/l after KPE), 2) survival with native liver (SNL), and 3) overall survival.</p><p><strong>Results: </strong>Use of steroids after KPE was associated with clearance of jaundice, 68% vs. 36.8% in the BA cases that did not receive steroids (P = 0.013; odds ratio 2.5) and a significantly better SNL rate at 2 - and 10-year of 62.22% and 57.77% vs. 39.47% and 31.57%, respectively (P = 0.01). A better 10-year SNL was observed in centers with caseload <1/year (group 1) as compared to centers that performed ≥1/year (group 2) [45.34% vs. 26.66%, respectively; P = 0.047]. On comparison of the 2 groups, cases in group 1 had KPE at significantly earlier age (median 59.5 vs. 75 days, P = 0.006) and received steroids after KPE more frequently than group 2 (69% vs. 31%, P < 0.001). None of the remaining prognostic variables were identified as being significantly related to BA outcome.</p><p><strong>Conclusion: </strong>Steroids use post-KPE predicted clearance of jaundice and better short- and long-term SNL. There is a need to establish a national BA registry in Saudi Arabia aiming to standardize the pre- and post-operative clinical practices and facilitate clinical and basic research to evaluate factors that influence BA outcome.</p>","PeriodicalId":48881,"journal":{"name":"Saudi Journal of Gastroenterology","volume":"29 5","pages":"286-294"},"PeriodicalIF":2.7,"publicationDate":"2023-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10645002/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"134650200","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Ramadan fasting model exerts hepatoprotective, anti-obesity, and anti-hyperlipidemic effects in an experimentally-induced nonalcoholic fatty liver in rats. 斋月禁食模型对实验性非酒精性脂肪肝大鼠具有肝保护、抗肥胖和抗高脂血症的作用。
IF 2.7 4区 医学 Q3 GASTROENTEROLOGY & HEPATOLOGY Pub Date : 2023-08-08 DOI: 10.4103/sjg.sjg_153_23
Abeer A Alasmari, Abdulrahman S Al-Khalifah, Ahmed S BaHammam, Noura M S Alshiban, Ahmad T Almnaizel, Hesham S Alodah, Maha H Alhussain

Background: The epidemic of nonalcoholic fatty liver disease (NAFLD) and its metabolic effects present a serious public health concern. We hypothesized that the Ramadan fasting model (RFM), which involves fasting from dawn to dusk for a month, could provide potential therapeutic benefits and mitigate NAFLD. Accordingly, we aimed to validate this hypothesis using obese male rats.

Methods: Rats were split into two groups (n = 24 per group), and they were given either a standard (S) or high-fat diet (HFD) for 12 weeks. During the last four weeks of the study period, both S- and HFD-fed rats were subdivided into eight groups to assess the effect of RFM with/without training (T) or glucose administration (G) on the lipid profile, liver enzymes, and liver structure (n = 6/group).

Results: The HFD+RFM group exhibited a significantly lower final body weight than that in the HFDC group. Serum cholesterol, low-density lipoprotein, and triglyceride levels were significantly lower in the HFD+RFM, HFD+RFM+T, and HFD+RFM+G groups than those in the HFDC group. Compared with the HFDC group, all groups had improved serum high-density lipoprotein levels. Furthermore, HFD groups subjected to RFM had reduced serum levels of aspartate transaminase and alanine transaminase compared with those of the HFD-fed group. Moreover, the liver histology improved in rats subjected to RFM compared with that of HFD-fed rats, which exhibited macro- and micro-fat droplet accumulation.

Conclusion: RFM can induce positive metabolic changes and improve alterations associated with NAFLD, including weight gain, lipid profile, liver enzymes, and hepatic steatosis.

背景:非酒精性脂肪性肝病(NAFLD)的流行及其代谢影响是一个严重的公共卫生问题。我们假设斋月禁食模式(RFM),包括从黎明到黄昏禁食一个月,可以提供潜在的治疗益处并减轻NAFLD。因此,我们的目的是用肥胖的雄性大鼠来验证这一假设。方法:将大鼠分为两组(每组24只),分别给予标准(S)和高脂(HFD)饮食12周。在研究期间的最后四周,将S-和hfd喂养的大鼠再分为8组,以评估RFM加/不加训练(T)或葡萄糖给药(G)对脂质谱、肝酶和肝脏结构的影响(n = 6/组)。结果:HFD+RFM组的最终体重明显低于HFDC组。HFD+RFM、HFD+RFM+T和HFD+RFM+G组血清胆固醇、低密度脂蛋白和甘油三酯水平均显著低于HFDC组。与HFDC组比较,各组血清高密度脂蛋白水平均有提高。此外,与饲料饲喂HFD组相比,饲料饲喂RFM的HFD组血清天冬氨酸转氨酶和丙氨酸转氨酶水平降低。此外,与饲喂hfd的大鼠相比,RFM大鼠肝脏组织学改善,出现宏观和微观脂肪滴积累。结论:RFM可以诱导积极的代谢变化,改善NAFLD相关的改变,包括体重增加、脂质谱、肝酶和肝脂肪变性。
{"title":"Ramadan fasting model exerts hepatoprotective, anti-obesity, and anti-hyperlipidemic effects in an experimentally-induced nonalcoholic fatty liver in rats.","authors":"Abeer A Alasmari,&nbsp;Abdulrahman S Al-Khalifah,&nbsp;Ahmed S BaHammam,&nbsp;Noura M S Alshiban,&nbsp;Ahmad T Almnaizel,&nbsp;Hesham S Alodah,&nbsp;Maha H Alhussain","doi":"10.4103/sjg.sjg_153_23","DOIUrl":"https://doi.org/10.4103/sjg.sjg_153_23","url":null,"abstract":"<p><strong>Background: </strong>The epidemic of nonalcoholic fatty liver disease (NAFLD) and its metabolic effects present a serious public health concern. We hypothesized that the Ramadan fasting model (RFM), which involves fasting from dawn to dusk for a month, could provide potential therapeutic benefits and mitigate NAFLD. Accordingly, we aimed to validate this hypothesis using obese male rats.</p><p><strong>Methods: </strong>Rats were split into two groups (n = 24 per group), and they were given either a standard (S) or high-fat diet (HFD) for 12 weeks. During the last four weeks of the study period, both S- and HFD-fed rats were subdivided into eight groups to assess the effect of RFM with/without training (T) or glucose administration (G) on the lipid profile, liver enzymes, and liver structure (n = 6/group).</p><p><strong>Results: </strong>The HFD+RFM group exhibited a significantly lower final body weight than that in the HFDC group. Serum cholesterol, low-density lipoprotein, and triglyceride levels were significantly lower in the HFD+RFM, HFD+RFM+T, and HFD+RFM+G groups than those in the HFDC group. Compared with the HFDC group, all groups had improved serum high-density lipoprotein levels. Furthermore, HFD groups subjected to RFM had reduced serum levels of aspartate transaminase and alanine transaminase compared with those of the HFD-fed group. Moreover, the liver histology improved in rats subjected to RFM compared with that of HFD-fed rats, which exhibited macro- and micro-fat droplet accumulation.</p><p><strong>Conclusion: </strong>RFM can induce positive metabolic changes and improve alterations associated with NAFLD, including weight gain, lipid profile, liver enzymes, and hepatic steatosis.</p>","PeriodicalId":48881,"journal":{"name":"Saudi Journal of Gastroenterology","volume":" ","pages":""},"PeriodicalIF":2.7,"publicationDate":"2023-08-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10029539","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Association between smoking and colorectal cancer in Eastern Mediterranean Regional Office (EMRO): A systematic review and meta-analysis. 东地中海区域办公室(EMRO)吸烟与结直肠癌之间的关系:一项系统综述和荟萃分析。
IF 2.7 4区 医学 Q3 GASTROENTEROLOGY & HEPATOLOGY Pub Date : 2023-07-04 DOI: 10.4103/sjg.sjg_163_23
Mohammad-Hossein Keivanlou, Ehsan Amini-Salehi, Soheil Hassanipour, Abinash Mahapatro, Nakka Raghuma, Farahnaz Joukar, Negin Letafatkar, Arman Habibi, Naeim Norouzi, Maryam Sadat Aleali, Mona Javid, Arian Mirdamadi, Fariborz Mansour-Ghanaei

Background: Smoking poses a significant risk for colorectal cancer (CRC), considered the third leading reason for cancer-related deaths worldwide. However, there has been limited research on the relationship between smoking and CRC in the Eastern Mediterranean Regional Office (EMRO). Therefore, a meta-analysis was conducted to combine available data and gain a comprehensive understanding of the relationship between smoking and CRC in EMRO.

Methods: Two independent researchers searched PubMed, Scopus, and Web of Science until December 2022. The included studies were checked for risk of bias administering the Newcastle-Ottawa scale. Heterogeneity was evaluated using I2 statistics and the Cochrane test. Publication bias was determined through funnel plot analysis and Egger's regression test. Additionally, a meta-regression analysis explored the impact of a country's Human Development Index (HDI) on the relationship between smoking and CRC.

Results: The final analysis included 26 studies, revealing a significant association between smoking and CRC (OR = 1.40; 95% CI: 1.11 - 1.78; P = 0.004). Moreover, smoking had a more pronounced adverse effect on CRC in countries with higher HDIs compared to those with lower HDIs (OR = 1.30; 95% CI: 0.99 - 1.71; P = 0.054).

Conclusions: Our findings underscore the importance of implementing smoking cessation programs and policies in EMRO countries, as they demonstrate a positive relationship between smoking and the risk of CRC. Furthermore, the results suggest that a country's level of human development may influence the association between smoking and CRC. Further research is needed to investigate this potential connection and develop targeted public health interventions.

背景:吸烟对结直肠癌(CRC)有显著的风险,结直肠癌被认为是全球癌症相关死亡的第三大原因。然而,东地中海区域办事处(EMRO)对吸烟与结直肠癌之间关系的研究有限。因此,我们进行了一项荟萃分析,结合现有数据,全面了解EMRO中吸烟与结直肠癌之间的关系。方法:两名独立研究人员检索PubMed、Scopus和Web of Science,直到2022年12月。采用纽卡斯尔-渥太华量表对纳入的研究进行偏倚风险检查。采用I2统计和Cochrane检验评估异质性。通过漏斗图分析和Egger回归检验确定发表偏倚。此外,荟萃回归分析探讨了一个国家的人类发展指数(HDI)对吸烟与结直肠癌之间关系的影响。结果:最终分析包括26项研究,揭示了吸烟与结直肠癌之间的显著关联(OR = 1.40;95% ci: 1.11 - 1.78;P = 0.004)。此外,与hdi较低的国家相比,在hdi较高的国家,吸烟对结直肠癌的不良影响更为明显(OR = 1.30;95% ci: 0.99 - 1.71;P = 0.054)。结论:我们的研究结果强调了在EMRO国家实施戒烟计划和政策的重要性,因为它们表明吸烟与结直肠癌风险之间存在正相关关系。此外,研究结果表明,一个国家的人类发展水平可能会影响吸烟与结直肠癌之间的关系。需要进一步研究来调查这种潜在联系并制定有针对性的公共卫生干预措施。
{"title":"Association between smoking and colorectal cancer in Eastern Mediterranean Regional Office (EMRO): A systematic review and meta-analysis.","authors":"Mohammad-Hossein Keivanlou,&nbsp;Ehsan Amini-Salehi,&nbsp;Soheil Hassanipour,&nbsp;Abinash Mahapatro,&nbsp;Nakka Raghuma,&nbsp;Farahnaz Joukar,&nbsp;Negin Letafatkar,&nbsp;Arman Habibi,&nbsp;Naeim Norouzi,&nbsp;Maryam Sadat Aleali,&nbsp;Mona Javid,&nbsp;Arian Mirdamadi,&nbsp;Fariborz Mansour-Ghanaei","doi":"10.4103/sjg.sjg_163_23","DOIUrl":"https://doi.org/10.4103/sjg.sjg_163_23","url":null,"abstract":"<p><strong>Background: </strong>Smoking poses a significant risk for colorectal cancer (CRC), considered the third leading reason for cancer-related deaths worldwide. However, there has been limited research on the relationship between smoking and CRC in the Eastern Mediterranean Regional Office (EMRO). Therefore, a meta-analysis was conducted to combine available data and gain a comprehensive understanding of the relationship between smoking and CRC in EMRO.</p><p><strong>Methods: </strong>Two independent researchers searched PubMed, Scopus, and Web of Science until December 2022. The included studies were checked for risk of bias administering the Newcastle-Ottawa scale. Heterogeneity was evaluated using I2 statistics and the Cochrane test. Publication bias was determined through funnel plot analysis and Egger's regression test. Additionally, a meta-regression analysis explored the impact of a country's Human Development Index (HDI) on the relationship between smoking and CRC.</p><p><strong>Results: </strong>The final analysis included 26 studies, revealing a significant association between smoking and CRC (OR = 1.40; 95% CI: 1.11 - 1.78; P = 0.004). Moreover, smoking had a more pronounced adverse effect on CRC in countries with higher HDIs compared to those with lower HDIs (OR = 1.30; 95% CI: 0.99 - 1.71; P = 0.054).</p><p><strong>Conclusions: </strong>Our findings underscore the importance of implementing smoking cessation programs and policies in EMRO countries, as they demonstrate a positive relationship between smoking and the risk of CRC. Furthermore, the results suggest that a country's level of human development may influence the association between smoking and CRC. Further research is needed to investigate this potential connection and develop targeted public health interventions.</p>","PeriodicalId":48881,"journal":{"name":"Saudi Journal of Gastroenterology","volume":" ","pages":""},"PeriodicalIF":2.7,"publicationDate":"2023-07-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10219892","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 3
Performance of artificial intelligence in the characterization of colorectal lesions. 人工智能在结直肠病变表征中的表现。
IF 2.7 4区 医学 Q3 GASTROENTEROLOGY & HEPATOLOGY Pub Date : 2023-07-01 DOI: 10.4103/sjg.sjg_316_22
Carlos E O Dos Santos, Daniele Malaman, Ivan D Arciniegas Sanmartin, Ari B S Leão, Gabriel S Leão, Júlio C Pereira-Lima

Background: Image-enhanced endoscopy (IEE) has been used in the differentiation between neoplastic and non-neoplastic colorectal lesions through microvasculature analysis. This study aimed to evaluate the computer-aided diagnosis (CADx) mode of the CAD EYE system for the optical diagnosis of colorectal lesions and compare it with the performance of an expert, in addition to evaluating the computer-aided detection (CADe) mode in terms of polyp detection rate (PDR) and adenoma detection rate (ADR).

Methods: A prospective study was conducted to evaluate the performance of CAD EYE using blue light imaging (BLI), dichotomizing lesions into hyperplastic and neoplastic, and of an expert based on the Japan Narrow-Band Imaging Expert Team (JNET) classification for the characterization of lesions. After white light imaging (WLI) diagnosis, magnification was used on all lesions, which were removed and examined histologically. Diagnostic criteria were evaluated, and PDR and ADR were calculated.

Results: A total of 110 lesions (80 (72.7%) dysplastic lesions and 30 (27.3%) nondysplastic lesions) were evaluated in 52 patients, with a mean lesion size of 4.3 mm. Artificial intelligence (AI) analysis showed 81.8% accuracy, 76.3% sensitivity, 96.7% specificity, 98.5% positive predictive value (PPV), and 60.4% negative predictive value (NPV). The kappa value was 0.61, and the area under the receiver operating characteristic curve (AUC) was 0.87. Expert analysis showed 93.6% accuracy, 92.5% sensitivity, 96.7% specificity, 98.7% PPV, and 82.9% NPV. The kappa value was 0.85, and the AUC was 0.95. Overall, PDR was 67.6% and ADR was 45.9%.

Conclusions: The CADx mode showed good accuracy in characterizing colorectal lesions, but the expert assessment was superior in almost all diagnostic criteria. PDR and ADR were high.

背景:图像增强内窥镜检查(IEE)已被用于通过微血管分析来区分肿瘤性和非肿瘤性结直肠病变。本研究旨在评估用于结直肠病变光学诊断的CAD EYE系统的计算机辅助诊断(CADx)模式,并将其与专家的性能进行比较,除了从息肉检出率(PDR)和腺瘤检出率(ADR)方面评估计算机辅助检测(CADe)模式外,以及基于日本窄带成像专家组(JNET)分类的用于表征病变的专家。在白光成像(WLI)诊断后,对所有病变进行放大,并对其进行切除和组织学检查。评估诊断标准,计算PDR和ADR。结果:52例患者共评估了110个病变(80个(72.7%)增生异常病变和30个(27.3%)非增生异常病变),平均病变大小为4.3mm。人工智能(AI)分析显示81.8%的准确性、76.3%的敏感性、96.7%的特异性、98.5%的阳性预测值(PPV)和60.4%的阴性预测值(NPV)。κ值为0.61,受试者工作特性曲线下面积(AUC)为0.87。专家分析显示准确率为93.6%,敏感性为92.5%,特异性为96.7%,PPV为98.7%,NPV为82.9%。kappa值为0.85,AUC为0.95。总体而言,PDR为67.6%,ADR为45.9%。结论:CADx模式在描述结直肠病变方面显示出良好的准确性,但专家评估在几乎所有诊断标准中都优于。PDR和ADR较高。
{"title":"Performance of artificial intelligence in the characterization of colorectal lesions.","authors":"Carlos E O Dos Santos,&nbsp;Daniele Malaman,&nbsp;Ivan D Arciniegas Sanmartin,&nbsp;Ari B S Leão,&nbsp;Gabriel S Leão,&nbsp;Júlio C Pereira-Lima","doi":"10.4103/sjg.sjg_316_22","DOIUrl":"10.4103/sjg.sjg_316_22","url":null,"abstract":"<p><strong>Background: </strong>Image-enhanced endoscopy (IEE) has been used in the differentiation between neoplastic and non-neoplastic colorectal lesions through microvasculature analysis. This study aimed to evaluate the computer-aided diagnosis (CADx) mode of the CAD EYE system for the optical diagnosis of colorectal lesions and compare it with the performance of an expert, in addition to evaluating the computer-aided detection (CADe) mode in terms of polyp detection rate (PDR) and adenoma detection rate (ADR).</p><p><strong>Methods: </strong>A prospective study was conducted to evaluate the performance of CAD EYE using blue light imaging (BLI), dichotomizing lesions into hyperplastic and neoplastic, and of an expert based on the Japan Narrow-Band Imaging Expert Team (JNET) classification for the characterization of lesions. After white light imaging (WLI) diagnosis, magnification was used on all lesions, which were removed and examined histologically. Diagnostic criteria were evaluated, and PDR and ADR were calculated.</p><p><strong>Results: </strong>A total of 110 lesions (80 (72.7%) dysplastic lesions and 30 (27.3%) nondysplastic lesions) were evaluated in 52 patients, with a mean lesion size of 4.3 mm. Artificial intelligence (AI) analysis showed 81.8% accuracy, 76.3% sensitivity, 96.7% specificity, 98.5% positive predictive value (PPV), and 60.4% negative predictive value (NPV). The kappa value was 0.61, and the area under the receiver operating characteristic curve (AUC) was 0.87. Expert analysis showed 93.6% accuracy, 92.5% sensitivity, 96.7% specificity, 98.7% PPV, and 82.9% NPV. The kappa value was 0.85, and the AUC was 0.95. Overall, PDR was 67.6% and ADR was 45.9%.</p><p><strong>Conclusions: </strong>The CADx mode showed good accuracy in characterizing colorectal lesions, but the expert assessment was superior in almost all diagnostic criteria. PDR and ADR were high.</p>","PeriodicalId":48881,"journal":{"name":"Saudi Journal of Gastroenterology","volume":"29 4","pages":"219-224"},"PeriodicalIF":2.7,"publicationDate":"2023-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/85/72/SJG-29-219.PMC10445495.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10066748","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 2
期刊
Saudi Journal of Gastroenterology
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1